Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04525638
Title A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion de investigacion HM

neuroendocrine tumor

pancreatic endocrine carcinoma

neuroendocrine carcinoma

pulmonary neuroendocrine tumor

gastrointestinal neuroendocrine tumor


lutetium Lu 177 dotatate + Nivolumab

Age Groups: senior | adult
Covered Countries ESP

No variant requirements are available.